{
    "info": {
        "nct_id": "NCT05155046",
        "official_title": "Phase II Trial of 18F-DCFPyL Imaging as a Method to Assess Treatment Response to Stereotactic Body Radiation Therapy",
        "inclusion_criteria": "* INCLUSION CRITERIA:\n* Biopsy proven localized prostate cancer in whom stereotactic body radiation treatment (SBRT) with or without neoadjuvant androgen deprivation therapy (ADT) is planned for definitive management (NIH laboratory of pathology confirmation is not required).\n* Must have at least 1 MRI detected, biopsy proven localized prostate cancer.\n* Age >= 18 years\n* ECOG performance status <= 2\n* For individuals with evidence of human immunodeficiency virus (HIV) infection, individuals must be on effective anti-retroviral therapy with undetectable viral load within the prior 6 months are eligible.\n* For individuals with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated.\n* For individuals with a history of hepatitis C virus (HCV), the infection must have been treated and cured. For individuals with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load.\n* Ability of subject to understand and the willingness to sign a written informed consent document.\n* Men must agree to use adequate contraception with their partner (hormonal or barrier method of birth control; abstinence) for the duration of study participation and 2 months after the last 18F-DCFPyL scan.\n\nEXCLUSION CRITERIA:\n\n* Receiving prior androgen deprivation therapy, radiotherapy, or surgery for prostate cancer.\n* Any condition that is likely to interfere with study procedures or results.\n* Individuals in whom pelvic nodal irradiation is planned.\n* Serum creatinine > 2 times the upper limit of normal.\n* Weighing > 350 lbs (weight limit for scanner table), or unable to fit in imaging gantry.\n* Evidence of tumor spread beyond the prostate/seminal vesicles (lymph nodes, metastases).\n* Contraindications to radiation or SBRT.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years\nMust have maximum age of 120 Years",
        "exclusion_criteria": "",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "* Individuals in whom pelvic nodal irradiation is planned.",
            "criterions": [
                {
                    "exact_snippets": "Individuals in whom pelvic nodal irradiation is planned",
                    "criterion": "pelvic nodal irradiation",
                    "requirements": [
                        {
                            "requirement_type": "planned",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must be MALE",
            "criterions": [
                {
                    "exact_snippets": "Must be MALE",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "male"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have maximum age of 120 Years",
            "criterions": [
                {
                    "exact_snippets": "maximum age of 120 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "maximum",
                            "expected_value": {
                                "operator": "<=",
                                "value": 120,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Receiving prior androgen deprivation therapy, radiotherapy, or surgery for prostate cancer.",
            "criterions": [
                {
                    "exact_snippets": "Receiving prior androgen deprivation therapy",
                    "criterion": "androgen deprivation therapy",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Receiving prior ... radiotherapy",
                    "criterion": "radiotherapy",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Receiving prior ... surgery for prostate cancer",
                    "criterion": "surgery for prostate cancer",
                    "requirements": [
                        {
                            "requirement_type": "history of treatment",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Any condition that is likely to interfere with study procedures or results.",
            "criterions": [
                {
                    "exact_snippets": "Any condition that is likely to interfere with study procedures or results.",
                    "criterion": "any condition interfering with study procedures or results",
                    "requirements": [
                        {
                            "requirement_type": "likelihood to interfere",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Serum creatinine > 2 times the upper limit of normal.",
            "criterions": [
                {
                    "exact_snippets": "Serum creatinine > 2 times the upper limit of normal.",
                    "criterion": "serum creatinine",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 2,
                                "unit": "times the upper limit of normal"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* For individuals with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated.",
            "criterions": [
                {
                    "exact_snippets": "evidence of chronic hepatitis B virus (HBV) infection",
                    "criterion": "chronic hepatitis B virus (HBV) infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "the HBV viral load must be undetectable on suppressive therapy, if indicated",
                    "criterion": "HBV viral load",
                    "requirements": [
                        {
                            "requirement_type": "detectability",
                            "expected_value": "undetectable"
                        },
                        {
                            "requirement_type": "suppressive therapy",
                            "expected_value": "if indicated"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* For individuals with a history of hepatitis C virus (HCV), the infection must have been treated and cured. For individuals with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load.",
            "criterions": [
                {
                    "exact_snippets": "history of hepatitis C virus (HCV) ... infection must have been treated and cured",
                    "criterion": "hepatitis C virus (HCV) infection",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "treatment_status",
                            "expected_value": "treated and cured"
                        }
                    ]
                },
                {
                    "exact_snippets": "HCV infection who are currently on treatment ... eligible if they have an undetectable HCV viral load",
                    "criterion": "HCV infection viral load",
                    "requirements": [
                        {
                            "requirement_type": "treatment_status",
                            "expected_value": "currently on treatment"
                        },
                        {
                            "requirement_type": "viral_load",
                            "expected_value": "undetectable"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* For individuals with evidence of human immunodeficiency virus (HIV) infection, individuals must be on effective anti-retroviral therapy with undetectable viral load within the prior 6 months are eligible.",
            "criterions": [
                {
                    "exact_snippets": "evidence of human immunodeficiency virus (HIV) infection",
                    "criterion": "HIV infection",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "must be on effective anti-retroviral therapy",
                    "criterion": "anti-retroviral therapy",
                    "requirements": [
                        {
                            "requirement_type": "treatment",
                            "expected_value": "effective anti-retroviral therapy"
                        }
                    ]
                },
                {
                    "exact_snippets": "undetectable viral load within the prior 6 months",
                    "criterion": "HIV viral load",
                    "requirements": [
                        {
                            "requirement_type": "detectability",
                            "expected_value": "undetectable"
                        },
                        {
                            "requirement_type": "time frame",
                            "expected_value": "within the prior 6 months"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Men must agree to use adequate contraception with their partner (hormonal or barrier method of birth control; abstinence) for the duration of study participation and 2 months after the last 18F-DCFPyL scan.",
            "criterions": [
                {
                    "exact_snippets": "Men must agree to use adequate contraception with their partner (hormonal or barrier method of birth control; abstinence) for the duration of study participation and 2 months after the last 18F-DCFPyL scan.",
                    "criterion": "contraception use",
                    "requirements": [
                        {
                            "requirement_type": "agreement to use contraception",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "contraception method",
                            "expected_value": [
                                "hormonal",
                                "barrier method of birth control",
                                "abstinence"
                            ]
                        },
                        {
                            "requirement_type": "duration",
                            "expected_value": "for the duration of study participation and 2 months after the last 18F-DCFPyL scan"
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "Years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Age >= 18 years",
            "criterions": [
                {
                    "exact_snippets": "Age >= 18 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum value",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Ability of subject to understand and the willingness to sign a written informed consent document.",
            "criterions": [
                {
                    "exact_snippets": "Ability of subject to understand",
                    "criterion": "subject's ability to understand",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "willingness to sign a written informed consent document",
                    "criterion": "willingness to sign informed consent",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Contraindications to radiation or SBRT.",
            "criterions": [
                {
                    "exact_snippets": "Contraindications to radiation",
                    "criterion": "contraindications to radiation",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "Contraindications to ... SBRT",
                    "criterion": "contraindications to SBRT",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* ECOG performance status <= 2",
            "criterions": [
                {
                    "exact_snippets": "ECOG performance status <= 2",
                    "criterion": "ECOG performance status",
                    "requirements": [
                        {
                            "requirement_type": "score",
                            "expected_value": {
                                "operator": "<=",
                                "value": 2,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Must have at least 1 MRI detected, biopsy proven localized prostate cancer.",
            "criterions": [
                {
                    "exact_snippets": "at least 1 MRI detected ... biopsy proven localized prostate cancer",
                    "criterion": "prostate cancer",
                    "requirements": [
                        {
                            "requirement_type": "detection_method",
                            "expected_value": [
                                "MRI",
                                "biopsy"
                            ]
                        },
                        {
                            "requirement_type": "localization",
                            "expected_value": "localized"
                        },
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">=",
                                "value": 1,
                                "unit": "N/A"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Weighing > 350 lbs (weight limit for scanner table), or unable to fit in imaging gantry.",
            "criterions": [
                {
                    "exact_snippets": "Weighing > 350 lbs (weight limit for scanner table)",
                    "criterion": "body weight",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 350,
                                "unit": "lbs"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "unable to fit in imaging gantry",
                    "criterion": "ability to fit in imaging gantry",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Biopsy proven localized prostate cancer in whom stereotactic body radiation treatment (SBRT) with or without neoadjuvant androgen deprivation therapy (ADT) is planned for definitive management (NIH laboratory of pathology confirmation is not required).",
            "criterions": [
                {
                    "exact_snippets": "Biopsy proven localized prostate cancer",
                    "criterion": "prostate cancer",
                    "requirements": [
                        {
                            "requirement_type": "diagnosis",
                            "expected_value": "biopsy proven"
                        },
                        {
                            "requirement_type": "stage",
                            "expected_value": "localized"
                        }
                    ]
                },
                {
                    "exact_snippets": "stereotactic body radiation treatment (SBRT) ... is planned for definitive management",
                    "criterion": "SBRT treatment plan",
                    "requirements": [
                        {
                            "requirement_type": "planned",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "with or without neoadjuvant androgen deprivation therapy (ADT)",
                    "criterion": "neoadjuvant androgen deprivation therapy (ADT)",
                    "requirements": [
                        {
                            "requirement_type": "planned",
                            "expected_value": "optional"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Evidence of tumor spread beyond the prostate/seminal vesicles (lymph nodes, metastases).",
            "criterions": [
                {
                    "exact_snippets": "Evidence of tumor spread beyond the prostate/seminal vesicles (lymph nodes, metastases)",
                    "criterion": "tumor spread beyond the prostate/seminal vesicles",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [],
    "miscellaneous_lines": [],
    "failed_inclusion": [
        {
            "line": "EXCLUSION CRITERIA:",
            "criterions": []
        },
        {
            "line": "* INCLUSION CRITERIA:",
            "criterions": []
        }
    ],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}